Glycemic assessment when hemoglobin A1c is unreliable: a clinical-laboratory framework for kidney disease, anemia, and hemoglobinopathies.

Wu T, Guan Z, Cai W

Open source

DOI
10.3389/fendo.2026.1898713
Published
2026
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1898713,
  title = {Glycemic assessment when hemoglobin A1c is unreliable: a clinical-laboratory framework for kidney disease, anemia, and hemoglobinopathies.},
  author = {Wu T and Guan Z and Cai W},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1898713},
  url = {https://doi.org/10.3389/fendo.2026.1898713}
}

RIS

TY  - JOUR
TI  - Glycemic assessment when hemoglobin A1c is unreliable: a clinical-laboratory framework for kidney disease, anemia, and hemoglobinopathies.
AU  - Wu T
AU  - Guan Z
AU  - Cai W
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1898713
UR  - https://doi.org/10.3389/fendo.2026.1898713
ER  - 

APA

T, W., Z, G., & W, C. (2026). Glycemic assessment when hemoglobin A1c is unreliable: a clinical-laboratory framework for kidney disease, anemia, and hemoglobinopathies.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1898713

Source records